Fasting insulin is exactly what it sounds like: a measurement of the insulin circulating in your blood after an overnight fast. It is one of the most information-dense biomarkers available in clinical medicine. It reveals how hard your pancreas is working, how sensitive your cells are to insulin’s signal, and how far along the metabolic dysfunction continuum you sit.
It is also almost never ordered on a standard panel. The reason is partly historical — fasting insulin assays were not widely standardized until relatively recently — and partly systemic. Standard preventive care is organized around diagnosing disease, not detecting dysfunction. Elevated fasting insulin is not a disease. It is a trajectory. And the medical system, by design, waits for trajectories to become diagnoses before acting.
The gap in standard care: A standard annual physical measures fasting glucose and HbA1c — both markers of blood sugar. Neither measures insulin directly. A patient can have a fasting insulin of 18 µIU/mL — indicating severe insulin resistance — with completely normal glucose and HbA1c. That patient will be told their labs are normal.
What Fasting Insulin Actually Measures
When you fast overnight and draw blood in the morning, the insulin level in that sample reflects your baseline pancreatic output — what your body requires just to maintain stable blood sugar at rest. In a metabolically healthy person, that number is low: typically below 6 µIU/mL. The cells respond readily to insulin’s signal, so the pancreas doesn’t need to produce much.
In a person with insulin resistance, the cells have become less responsive. The pancreas compensates by producing more insulin to achieve the same effect. Blood sugar stays normal — because the pancreas is working harder — but fasting insulin climbs. A value of 10, 15, or 20 µIU/mL indicates that the compensatory mechanism is active, even if glucose looks fine. This compensation phase is the window for intervention. It is also entirely invisible to standard lab panels.
HOMA-IR: Turning Two Numbers Into a Precise Picture
Fasting insulin alone is informative, but its interpretation depends on fasting glucose. HOMA-IR — the Homeostatic Model Assessment of Insulin Resistance — combines both into a single calculated value that quantifies resistance directly.
The formula is straightforward: HOMA-IR = (fasting insulin × fasting glucose) ÷ 405 (when glucose is in mg/dL).
| HOMA-IR Value | Clinical Interpretation | Valens MD Tier | Typical Fasting Glucose |
|---|---|---|---|
| < 1.0 | Optimal insulin sensitivity | Tier 1 | 70–85 mg/dL |
| 1.0–2.0 | Early insulin resistance | Tier 2 | 85–95 mg/dL |
| 2.0–4.0 | Established insulin resistance | Tier 3 | 90–105 mg/dL |
| > 4.0 | Significant resistance / high risk | Tier 4 | 100–125 mg/dL |
The TyG Index: A Second Lens on the Same Problem
The Triglyceride-Glucose (TyG) Index uses fasting triglycerides and fasting glucose to estimate insulin resistance through a different biological pathway. It has been validated in large population studies as a strong predictor of cardiovascular risk and metabolic dysfunction.
At Valens MD, we use both HOMA-IR and TyG Index together. When they agree — both elevated — the picture is clear. When they diverge, it provides diagnostic signal about which pathway is driving the dysfunction, which informs the protocol.
Why the TG:HDL ratio matters too: A triglyceride-to-HDL ratio above 2.0 is one of the most reliable clinical proxies for insulin resistance in routine practice. It reflects the same underlying metabolic dysregulation as elevated fasting insulin — excess hepatic triglyceride production driven by chronic hyperinsulinemia. It also appears on every standard lipid panel, which means most patients already have this data — they just haven’t been told what it means.
What Elevated Fasting Insulin Actually Causes
Chronically elevated insulin — independent of blood sugar — drives a cascade of downstream effects. Insulin promotes fat storage and inhibits fat breakdown, which is why visceral fat accumulates even in people who exercise. It drives sodium retention in the kidneys, contributing to blood pressure elevation. It stimulates inflammatory pathways and promotes endothelial dysfunction — the earliest stage of arterial disease.
In the brain, insulin resistance impairs glucose uptake in key regions including the prefrontal cortex and hippocampus, which explains the cognitive symptoms — brain fog, difficulty sustaining focus, memory impairment — that patients at Tier 3 frequently report and that are consistently attributed to stress, aging, or sleep rather than investigated metabolically.
How to Interpret Your Own Numbers
If you have recent labs, you may already have the data you need. Fasting glucose appears on most comprehensive metabolic panels. Triglycerides and HDL appear on lipid panels. From those three numbers alone, you can calculate your TG:HDL ratio and get a directional sense of your metabolic position. What you cannot calculate from standard labs is HOMA-IR — because that requires fasting insulin, which requires a separate order. At Valens MD, that order is part of every initial evaluation, along with interpretation in the context of your full picture.
Valens MD Clinical Team
The Valens MD Clinical Team consists of board-certified physicians specializing in metabolic health, longevity, and wellness medicine. Our physician-led approach combines advanced diagnostics with personalized, evidence-based care.
